Abstract:The development of cationic polymers as alternative materials to antibiotics necessitates addressing the challenge of balancing their antimicrobial activity and toxicity. Here we propose a precise switching strategy inspired by biomimetic voltage-gated ion channels, enabling controlled activation and inhibition of cationic antimicrobial functions through protein conformational transitions in diverse physiological environments. Following thermodynamic studies on the specific recognition between mannose end groups on polycations and concanavalin A (ConA), we synthesized a type of ConA-polycation nanoparticle. The nanoparticle was inhibited under neutral conditions, with cationic moieties shielded by ConA's β -sheet. This shielding suppresses their antimicrobial activity, thereby ensuring satisfactory biocompatibility. In mildly acidic environments, however, the transition of a portion of ConA to an α -helix conformation exposed cations at the particle periphery, activating antibacterial functionality. Compared to inhibited nanoparticles, those in the activated state exhibited a 32–256 times reduction in the minimum bactericidal concentration against bacteria and fungi (2–16 μg/mL). In a murine acute pulmonary infection model, intravenous administration of inhibited nanoparticles effectively reduced bacterial counts by 4-log within 12 h. The biomimetic design, regulating cationic antimicrobial functionality through the alteration in protein secondary structure, significantly retards bacterial resistance development, holding great promise for intelligent antimicrobial materials. Statement of significance Cationic antimicrobial polymers exhibit advantages distinct from antibiotics due to their lower propensity for resistance development. However, the presence of cationic moieties also poses a threat to healthy cells and tissues, significantly constraining their potential for clinical applications. To address this challenge, we propose a biomimetic strategy that mimics voltage-gated ion channels to activate the antimicrobial functionality of cations selectively in bacterial environments through the conformational transitions of proteins between β –sheets and α –helices. In healthy tissues, the antimicrobial functionality is inhibited, ensuring satisfactory biocompatibility. Antimicrobial cationic materials capable of intelligent switching between an activated state and an inhibited state in response to environmental changes offer an effective strategy to prevent the development of resistance and mitigate potential side effects.

Designer Small-Molecule Control System Based on Minocycline-Induced Disruption of Protein-Protein Interaction

A rational blueprint for the design of chemically-controlled protein switches

Design of a methotrexate-controlled chemical dimerization system and its use in bio-electronic devices

A tunable, rapid, and precise drug control of protein expression by combining transcriptional and post-translational regulation systems

Turning antibodies off and on again using a covalently tethered blocking peptide

Tackling Undruggable Targets with Designer Peptidomimetics and Synthetic Biologics

In silico design of anti-tumor mini-protein targeting MDM2

High-Throughput Miniaturized Synthesis of PROTAC-Like Molecules

A small molecule-directed approach to control protein localization and function

De novo design of miniprotein antagonists of cytokine storm inducers

Design of an allosterically modulated doxycycline and doxorubicin drug-binding protein

Preclinical proof of principle for orally delivered Th17 antagonist miniproteins

Simultaneous Control of Endogenous and User-Defined Genetic Pathways Using Unique ecDHFR Pharmacological Chaperones

Targeted protein degradation in mycobacteria uncovers antibacterial effects and potentiates antibiotic efficacy

Chemical optimization and derivatization of micrococcin p2 to target multiple bacterial infections: new antibiotics from thiopeptides

Biomimetic protein structural transitions regulate activation and inhibition of the broad-spectrum bactericidal activity of cationic nanoparticles

Structure-guided design and cloning of peptide inhibitors targeting CDK9/cyclin T1 protein-protein interaction

Exploiting protein domain modularity to enable synthetic control of engineered cells

Targeted Protein Degradation: The New Frontier of Antimicrobial Discovery?

Human antibody-based chemically induced dimerizers for cell therapeutic applications

Multiplexing bacteriocin synthesis to kill and prevent antimicrobial resistance